Explore more publications!

California Health Watch: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on California Health Watch.

Press releases published on November 14, 2025

TOMI Environmental Solutions, Inc. Reports Q3 2025 Financial Results and Outlines Growth Initiatives
Femasys Announces Third Quarter Financial Results for 2025
Inhibikase Therapeutics Announces Third Quarter 2025 Financial Results and Highlights Recent Activity
Annexon Announces Closing of Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares for Gross Proceeds of $86.25 Million
Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026
Nove Device Expands Access to Lifesaving Naloxone Nasal Spray Carry Case
Nove Device Introduces Innovative Naloxone Nasal Spray Carry Case for Emergency Preparedness
FDA Approves New Safety Warning and Revised Indication that Limits Use for Elevidys Following Reports of Fatal Liver Injury
Tevogen Highlights Continued Capital Efficiency Following Filing of Q3 2025 Form 10-Q
Global Sound Practitioner Alliance Honors Tina Cowle with the 2025 Rising Impact Award
Positioning Barbados as the Caribbean’s Life Sciences Hub
SEQUANA MEDICAL ANNOUNCES NEW SHARE CAPITAL AMOUNT AND NEW NUMBER OF SHARES
Truveta research published in JAMA Network Open shows rapid uptake of early measles vaccination during Texas outbreak
Press Release Biocartis NV: Biocartis Showcases Growing Impact of Idylla™ Platform at AMP 2025
MediPharm Announces Complete Dismissal of Defamation Action Initiated by Apollo, Nobul and Regan McGee Under Ontario Anti-SLAPP Law
Wayman Place Partners with SafeSpace Global to Enhance Resident Safety with Non-Wearable Elopement Detection
Allarity Therapeutics Provides Third Quarter 2025 Financial Results and Provides Business Updates
GT Biopharma Reports Third Quarter 2025 Financial Results and Provides Corporate Update
Vaso Corporation Announces Financial Results for Third Quarter of 2025
Windtree Therapeutics Announces More Strengthening of Its Istaroxime and Next Generation SERCA2a activator Patent Estate

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions